How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Antibodies from llamas could be used to create a new generation of ...

Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...

Please provide your email address to receive an email when new articles are posted on . Cobenfy is the first antipsychotic medication to treat schizophrenia by targeting cholinergic receptors. The ...

Charlene Sunkel was 19 when she started hearing voices and strange thoughts began filling her head. People wanted to infiltrate her mind, to poison her, to rat her out to the police. She stopped ...

This post was co-authored by Shontae Cameron, and Robert T. Muller, Ph.D. The World Health Organization estimates that schizophrenia affects around 24 million people, or roughly 1 in 300 individuals ...

New guidelines have been developed for the treatment of schizophrenia through a collaborative effort of international experts from 30 countries. The recommendations are published in The Lancet ...

The FDA has paused new patient enrollment in a phase III trial of evenamide for treatment-resistant schizophrenia following ...

The general consensus among experts is that TRS is a condition in which an individual’s symptoms haven’t responded to two or more antipsychotic medicines given at a therapeutic dose for at least six ...